A detailed history of Sanctuary Advisors, LLC transactions in Vericel Corp stock. As of the latest transaction made, Sanctuary Advisors, LLC holds 10,982 shares of VCEL stock, worth $437,742. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,982
Previous 5,789 89.7%
Holding current value
$437,742
Previous $246 Million 94.07%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Jan 06, 2026

BUY
$29.84 - $41.74 $154,959 - $216,755
5,193 Added 89.7%
10,982 $478 Million
Q2 2025

Jan 06, 2026

BUY
$37.92 - $45.7 $22,600 - $27,237
596 Added 11.48%
5,789 $246 Million
Q1 2025

Jan 06, 2026

BUY
$44.5 - $61.8 $8,010 - $11,124
180 Added 3.59%
5,193 $232 Million
Q4 2024

Jan 31, 2025

BUY
$40.05 - $59.11 $25,271 - $37,298
631 Added 14.4%
5,013 $297 Million
Q3 2024

Nov 25, 2024

BUY
$42.25 - $53.56 $185,139 - $234,699
4,382 New
4,382 $259 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $1.88B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Sanctuary Advisors, LLC Portfolio

Follow Sanctuary Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanctuary Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanctuary Advisors, LLC with notifications on news.